EP 1812032 A4 20090902 - TISSUE FACTOR COMPOSITION AND METHODS
Title (en)
TISSUE FACTOR COMPOSITION AND METHODS
Title (de)
GEWEBEFAKTORZUSAMMENSETZUNG UND VERFAHREN
Title (fr)
COMPOSITION A BASE DE FACTEUR TISSULAIRE ET METHODES ASSOCIEES
Publication
Application
Priority
- US 2005038781 W 20051027
- US 62273704 P 20041027
Abstract (en)
[origin: WO2006047684A2] Tissue Factor (natural or recombinant truncated) can be incorporated into stable, soluble nanoscale particles so that activity is maintained. These particles can be used as a reagent in prothrombin clotting time assays or they can be used in therapeutic compositions for use in humans or animals. Therapeutic settings can include supplementation in the case of a genetic deficiency, uncontrolled bleeding, surgical incisions or seepage, thrombocytopenia, soft tissue trauma or other trauma, to effect tumor regression or to inhibit tumor growth.
IPC 8 full level
A61K 9/127 (2006.01); A61K 38/00 (2006.01); C07K 14/00 (2006.01); C07K 14/745 (2006.01)
CPC (source: EP)
A61K 9/127 (2013.01); A61K 9/5123 (2013.01); A61K 9/5169 (2013.01); A61K 38/363 (2013.01); C07K 14/745 (2013.01)
Citation (search report)
- [XD] WO 0240501 A2 20020523 - UNIV ILLINOIS [US]
- [XD] US 2004053384 A1 20040318 - SLIGAR STEPHEN G [US], et al
- See references of WO 2006047684A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006047684 A2 20060504; WO 2006047684 A3 20060727; EP 1812032 A2 20070801; EP 1812032 A4 20090902
DOCDB simple family (application)
US 2005038781 W 20051027; EP 05825139 A 20051027